Mechanisms of deficient interferon-γ production in atopic diseases

Clinical and Experimental Allergy

Volumn 29, Issue 7, 1999, Pages 912-919

  Jung, T ^a,b   Moessner, R ^a   Dieckhoff, K ^a   Heidrich, S ^a   Neumann, C ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NOVARTIS RESEARCH INSTITUTE   (Austria)

Author keywords

Cytokines; Human; Inteferon , naive CD4+ T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032981134     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00619.x     Document Type: Article

References (41)

1. Leung DY. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995; 96:302-18.
2. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-76.
3. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol 1992; 4:314-20.
4. van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA. Prostaglandin E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995; 181:775-9.
5. Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. IL-12-deficient dendritic cells. Generated presence prostaglandin E2 promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997; 159:28-35.
6. Hanifin JM, Chan SC. Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis. J Invest Dermatol 1995; 105:84S-8S.
7. Chan S, Henderson WR Jr, Li SH, Hanifin JM. Prostaglandin E2 control of T cell cytokine production is functionally related to the reduced lymphocyte proliferation in atopic dermatitis. J Allergy Clin Immunol 1996; 97:85-94.
8. Snijders A, van der Pouw Kraan TC, Engel M et al. Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12. Clin Exp Immunol 1998; 111:472-6.
9. Reinhold U, Wehrmann W, Kukel S, Kreysel HW. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin Exp Immunol 1990; 79:374-9.
10. Jung T, Lack G, Schauer U et al. Decreased frequency of interferon-γ- and interleukin-2-producing cells in patients with atopic diseases measured at the single cell level. J Allergy Clin Immunol 1995; 96:515-27.
11. + cells in the peripheral blood of patients with atopic dermatitis. Exp Dermatol 1998; 7:112-8.
12. Jung T, Witzak K, Dieckhoff K et al. Mechanisms of deficient interferon-gamma production in atopic diseases. IFN-γ production is only partially restored by costimulation of peripheral T cells with IL-12, IL-2, IL-15, IL-18 or engagement of CD28. Clin Exp Allergy 1999; 29:207-16.
13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Suppl.) Stockh 1980; 92:44-7.
14. Severity scoring of atopic dermatitis. The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatol 1993; 186:23-31.
15. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Meth 1993; 159:197-207.
16. Bauer H, Jung T, Tsikas D, Stichtenoth DO, Frölich JC, Neumann C. Nitric oxide inhibits the secretion of T-helper 1 and T-helper 2 associated cytokines in activated human T-cells. Immunol 1997; 90:205-11.
17. + T cells. Modulation by interleukin-4 and interleukin-12. Eur J Immunol 1996; 26:571-7.
18. Peleman R, Fargeas C, Wu JP, Delespesse G. IL-4 suppresses the production of IFN-γ by human lymphocytes. J Exp Med 1989; 170:1751-61.
19. Rousset F, Robert J, Andary M et al. Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol 1991; 87:58-69.
20. Renz H, Jujo K, Bradley KL, Domenico J, Gelfand EW, Leung DY. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 1992; 99:403-8.
21. Jujo K, Renz H, Abe J, Gelfand EW, Leung DY. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992; 90:323-31.
22. Chan SC, Li SH, Hanifin JM. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J Invest Dermatol 1993; 100:681-4.
23. Khurana Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N Engl J Med 1997; 337:1720-5.
24. + cells in patients with atopic dermatitis. J Allergy Clin Immnol 1997; 99:673-82.
25. Tang ML, Kemp AS, Thorburn J, Hill DJ. Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet 1994; 344:983-5.
26. Warner JA, Miles EA, Jones AC, Quint DJ, Colwell BM, Warner JO. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema? Clin Exp Allergy 1994; 24:423-30.
27. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 1995; 181:713-21.
28. Lester MR, Hofer MF, Gately M, Trumble A, Leung DY. Down-regulating effects of IL-4 und IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 1995; 154:6174-81.
29. Kapp A. Atopic dermatitis - the skin manifestation of atopy. Clin Exp Allergy 1995; 25:210-9.
30. Ehlers S, Smith KA. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 1991; 173:25-36.
31. Demeure CE, Yang LP, Byun DG, Ishihara H, Vezzio N, Delespesse G. Human naive CD4 T cells produce interleukin-4 at priming and acquire a Th2 phenotype upon repetitive stimulations in neutral conditions. Eur J Immunol 1995; 25:2722-5.
32. Finkelman FD, Madden KB, Morris SC et al. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol 1993; 151:1235-44.
33. Bradding P, Feather IH, Howarth PH et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992; 176:1381-93.
34. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by IL-3 produce IL-4 in response to IgE receptor stimulation. J Exp Med 1993; 177:605-14.
35. van der Pouw Kraan TC, Boeije LC, de Groot ER et al. Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J Immunol 1997; 158:5560-5.
36. + T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J Immunol 1995; 155:4604-12.
37. Chan SC, Kim JW, Henderson WR Jr, Hanifin JM. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 1993; 151:3345-52.
38. Beverley PC. Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin Immunol 1992; 4:35-41.
39. + T-cell memory. CD45R subsets and the persistence of antigen - a unifying concept. Immunol Today 1998; 19:60-4.
40. + unprimed T cells. J Immunol 1994; 152:5613-23.
41. + T cell lines from naive precursors. Eur J Immunol 1995; 25:1206-11.